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Abstract
Background: The amyloid precursor protein (APP) is cleaved by b- and g-secretases to generate toxic amyloid b
(Ab) peptides. Alternatively, a-secretases cleave APP within the Ab domain, precluding Ab formation and releasing
the soluble ectodomain, sAPPa. We previously showed that inhibition of the GTPase dynamin reduced APP
internalization and increased release of sAPPa, apparently by prolonging the interaction between APP and a-
secretases at the plasma membrane. This was accompanied by a reduction in Ab generation. In the present study,
we investigated whether surface expression of the a-secretase ADAM (a disintegrin and metalloprotease)10 is also
regulated by dynamin-dependent endocytosis.
Results: Transfection of human embryonic kidney (HEK) cells stably expressing M3 muscarinic receptors with a
dominant negative dynamin I mutant (dyn I K44A), increased surface expression of both immature, and mature,
catalytically active forms of co-expressed ADAM10. Surface levels of ADAM10 were unaffected by activation of
protein kinase C (PKC) or M3 receptors, indicating that receptor-coupled shedding of the ADAM substrate APP is
unlikely to be mediated by inhibition of ADAM10 endocytosis in this cell line. Dyn I K44A strongly increased the
formation of a C-terminal fragment of ADAM10, consistent with earlier reports that the ADAM10 ectodomain is
itself a target for sheddases. The abundance of this fragment was increased in the presence of a g-secretase
inhibitor, but was not affected by M3 receptor activation. The dynamin mutant did not affect the distribution of
ADAM10 and its C-terminal fragment between raft and non-raft membrane compartments.
Conclusions: Surface expression and limited proteolysis of ADAM10 are regulated by dynamin-dependent
endocytosis, but are unaffected by activation of signaling pathways that upregulate shedding of ADAM substrates
such as APP. Modulation of ADAM10 internalization could affect cellular behavior in two ways: by altering the
putative signaling activity of the ADAM10 C-terminal fragment, and by regulating the biological function of
ADAM10 substrates such as APP and N-cadherin.
Keywords: a disintegrin and metalloprotease (ADAM)10 dynamin, amyloid precursor protein (APP), muscarinic
receptor, protein kinase C (PKC), endocytosis
Background
The pathogenesis of Alzheimer’s disease (AD) is due, at
least in part, to the formation in brain of insoluble pro-
tein deposits known as amyloid plaques. The principal
component of the plaques, a neurotoxic, self-aggregating
peptide known as amyloid b (Ab), is generated by suc-
cessive cleavage of the amyloid precursor protein (APP)
by b-a n dg-secretases. Alternatively, APP may be
cleaved within its Ab domain by a-secretases, preclud-
ing the formation of Ab, and releasing sAPPa,al a r g e
soluble N-terminal fragment, from the cell surface. An
alteration in the balance between these alternative pro-
teolytic pathways may underlie the pathogenic process
in AD [1-3]. Recent research has identified the ADAM
(a disintegrin and metalloprotease) family of zinc metal-
loproteases, particularly ADAM10 and ADAM17/TACE
(tumor necrosis factor a convertase), as a-secretases
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any medium, provided the original work is properly cited.[4,5]. ADAMs cleave a variety of transmembrane pro-
teins, including APP, within their extracellular domains,
resulting in shedding of the ectodomain fragment [4].
Multiple receptor ligands, as well as direct activators of
protein kinase C (PKC), stimulate ectodomain shedding
of APP and other proteins [6]. However, phosphoryla-
tion of the cytoplasmic domain of APP does not appear
to be necessary for signal-regulated shedding of APP
[7,8]. Neither does truncation of the cytoplasmic domain
of ADAM17 prevent upregulation of its activity toward
several of its substrates, including tumor necrosis factor
a, by phorbol ester [9,10]. On the other hand, signal-
activated shedding of TrkA and the prion protein was
reported to be at least partially dependent on phosphor-
ylation of threonine 735 within the cytoplasmic domain
of ADAM17/TACE by mitogen-activated protein kinase
[11,12]. Taken together, the evidence suggests that mul-
tiple mechanisms contribute to signal-mediated upregu-
lation of ectodomain shedding by ADAMs.
Mutation of internalization motifs within the C-termi-
nus of APP, or removal of the C-terminal tail, increases
surface expression of APP, and release of sAPPa [13,14].
Blocking the function of the endocytic protein dynamin
by transfecting cells with dyn I K44A, a dominant-nega-
tive dynamin I mutant [15], exerts similar effects [16,17]
suggesting that inhibition of endocytosis promotes ecto-
domain shedding by prolonging the interaction between
APP and a-secretases on the plasma membrane.
Because PKC phosphorylates dynamin, preventing it
from associating with membrane phospholipids [18], we
hypothesized that inhibition of dynamin function might
be the mechanism underlying kinase-dependent sAPPa
release. However, the PKC activator phorbol 12-myris-
tate 13-acetate (PMA) did not affect the rate of APP
internalization in HEK cells stably transfected with
APP695 [17].
It was recently reported that ADAM10 is cleaved
within its ectodomain by ADAM9 or ADAM15, generat-
ing a C-terminal fragment (CTF) that is then proteo-
lyzed by g-secretase [19-21]. The released intracellular
domain subsequently translocates to the nucleus [19].
Thus, like APP, ADAM10 undergoes sequential two-
step proteolysis to generate a fragment with potential
signaling capabilities. Our results show that inhibition of
dynamin-dependent endocytosis increases surface
expression of mature ADAM10, and potentiates the for-
mation of the ADAM10 CTF. Activation of PKC, or M3
muscarinic receptors, did not affect ADAM10 surface
expression or CTF formation, suggesting that receptor-
or PKC-mediated stimulation of APP shedding in these
cells is not dependent on alterations in ADAM10 traf-
ficking or proteolysis. Other physiological mechanisms
that could regulate ADAM10 internalization, such as
interactions with other cell surface proteins, have the
potential to alter generation of the CTF, thereby modu-
lating its putative signaling actions.
Results
Inhibition of dynamin function increases surface
expression of ADAM10
Inhibition of dynamin-dependent internalization of APP
promotes its cleavage at the cell surface by a-secretases
[16,17]. To determine if dynamin also regulates interna-
lization of ADAM10, HEK-M3 cells were transiently
transfected with ADAM10 and either dyn I K44A or an
empty vector. After 48 h, cells were surface-biotinylated,
lysed, and analyzed by Western blotting. In vector-trans-
fected cells, biotinylated endogenous ADAM10 appeared
as one band, corresponding to the mature form, which
lacks the inhibitory prodomain (Figure 1A). The latter is
removed by the action of proprotein convertases to gen-
erate the mature active form [22]. Overexpression of
ADAM10 increased surface levels of mature ADAM10,
and a second faint band representing the immature pro-
form was also detected (Figure 1A, upper panel). In cells
co-expressing ADAM10 and dyn I K44A, surface levels
Figure 1 Surface expression of ADAM10 is increased by dyn I
K44A overexpression. HEK-M3 cells were transiently transfected
with ADAM10, dyn I K44A, or empty vector as indicated. After 48 h,
cells were surface-biotinylated and lysed. Biotinylated proteins and
cell lysates were analyzed by immunoblotting. A. Bands
representing biotinylated immature (im) and mature (m) ADAM10
on the cell surface are indicated by arrows (upper panel). Cell
lysates were immunoblotted with antibodies to ADAM10 (middle
panel) and dynamin I (lower panel). B. Surface levels of mature and
immature ADAM10 in cells co-expressing ADAM10 and dyn I K44A
were quantitated and normalized relative to levels in cells co-
expressing ADAM10 and empty vector. Results are expressed as
means ± SEM from five experiments. *Significantly different from
ADAM/vector control.
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cantly increased compared to ADAM10/vector-trans-
fected cells (Figure 1A, upper panel, and 1B). Mature
ADAM10 at the cell surface was greatly enriched rela-
tive to the immature form of the protein; the reverse of
the pattern observed in cell lysates (Figure 1A, middle
panel). Interestingly, immature ADAM10 on the cell
surface accumulated in the presence of the dynamin
mutant to a greater degree than the mature form (Fig-
ure 1B). Although only cells overexpressing ADAM10
displayed the immature form on the cell surface, the
results suggest that both mature and immature
ADAM10 are internalized in a dynamin-dependent
fashion.
To confirm the identity of the anti-ADAM10-immu-
noreactive bands observed in surface-biotinylated iso-
lates, cells co-transfected with ADAM10 and either
APP695 or empty vector, were treated with a competitive
inhibitor of proprotein convertases, decanoyl-arg-val-lys-
arg-chloromethylketone (dec-RVKR-CMK) [22,23], or
DMSO. In cells transfected with ADAM10, the inhibitor
increased levels of the immature form of ADAM10 on
the cell surface, and in cell lysates (Figure 2A). The
release of both endogenous sAPPa, and co-transfected
sAPPa695, was concomitantly reduced in the presence of
the inhibitor (Figure 2B). This is consistent with a
reduction in mature active ADAM10, and with inhibi-
tion of endogenous ADAMs, including TACE, by dec-
RVKR-CMK, and is in agreement with previously pub-
lished reports [22,24].
ADAM10 overexpression increases constitutive, but not
M3 receptor-evoked release of sAPPa
In view of evidence that ADAM10 is preferentially acti-
vated by agents that increase calcium influx [25,26], we
examined the effect of the muscarinic receptor agonist
carbachol on ADAM10 surface expression and a-secre-
tase function. Previous work from this laboratory
showed that a calcium ionophore stimulates sAPPa
release from HEK-M3 cells, and that carbachol-mediated
sAPPa release from these cells is partially dependent on
calcium [27]. In HEK-M3 cells transiently transfected
with APP695, co-expression of ADAM10 increased basal
sAPPa release, while causing no further change in car-
bachol-evoked release, and sharply reduced surface
levels of APP (Figure 3A and 3C). Conversely, co-
expression with APP695 increased surface expression of
immature ADAM10, while leaving levels of mature
ADAM10 unchanged (Figure 3A and 3C). Carbachol
had no effect on surface expression of ADAM10 (Figure
3A and 3C), and, despite the ability of PKC to regulate
endocytosis of multiple cell surface proteins [28,29],
PMA was similarly ineffective (data not shown). Overall,
these results support a role for ADAM10 as a regulator
of constitutive sAPPa shedding, but suggest that neither
stimulation of M3 receptors, nor direct activation of
PKC, affect surface expression of ADAM10 in this cell
line.
Proteolytic processing of ADAM10 is increased by
dynamin inhibition, but is unaffected by carbachol
It has been reported that ADAM10 is cleaved within its
ectodomain by ADAM9 or ADAM15, generating a CTF
that is subsequently proteolyzed by g-secretase [19-21].
In agreement with this study, a fragment of approxi-
mately 16 kDa was observed in cell lysates derived from
HEK-M3 cells transfected with ADAM10 and probed
with antibodies to the ADAM10 C-terminus (Figure 4).
Levels of the CTF were increased several fold in cells
co-transfected with dyn I K44A. The g-secretase inhibi-
tor L-685,458 significantly increased the abundance of
this fragment in co-transfected cells. The inhibitor also
tended to increase CTF levels in ADAM10/vector
Figure 2 A proprotein convertase inhibitor increases surface
expression and cellular levels of immature ADAM10. A. HEK-M3
cells were transiently transfected with ADAM10. After 48 h, cells
were pre-treated with DMSO or the proprotein convertase inhibitor,
dec-RVKR-CMK, for 2 h. Cells were surface-biotinylated and lysed.
Biotinylated proteins and cell lysates were immunoblotted with
antibodies to ADAM10. Levels of biotinylated immature ADAM10
were quantitated and expressed as means ± SEM from five
experiments. *Significantly different from control group. B. Cells co-
transfected with ADAM10 and APP695 were treated with DMSO or
dec-RVKR-CMK for 2 h. Fresh serum-free medium with DMSO or
dec-RVKR-CMK was then placed on the cells and the medium was
collected 2 h later. Medium extracts were immunoblotted with 6E10
antibodies, and lysates with antibodies to the APP C-terminus.
Levels of sAPPa695 in the medium were quantitated, normalized to
control values, and expressed as means ± SEM from 5 experiments.
*Significantly different from control values.
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significant (Figure 4B). A smaller, ~10 kDa fragment
was observed in ADAM10/dyn I K44A co-transfectants,
but was much less abundant, and appeared to be unaf-
fected by the inhibitor (Figure 4A). Although we were
unable to detect ADAM10 immunoreactivity in the
medium of ADAM10/dyn I K44A co-transfectants after
a 2 h collection period, using the method described by
Tousseyn et al. [19], the increased abundance of the
ADAM10 CTF in lysates from cells co-transfected with
dyn I K44A suggests that, like APP [17], ADAM10 pro-
teolysis at the cell surface is increased when its interna-
lization is inhibited. Although shedding of the ADAM10
ectodomain was reported to be increased by phorbol
ester in SH-SY5Y neuroblastoma cells [20], treatment of
HEK-M3 cells with carbachol had no effect on the gen-
eration of the ADAM10 CTF, either in the presence or
absence of dyn I K44A (Figure 5). Under identical con-
ditions, this concentration of carbachol, which also
Figure 3 Activation of muscarinic M3 receptors increases
constitutive release of sAPPa, but does not affect ADAM10
surface expression. A. HEK-M3 cells were transfected with
ADAM10, APP695, or empty vector as indicated. After 48 h cells were
pre-incubated for 1 h in serum-free DMEM, then incubated in fresh
DMEM in the presence of carbachol (100 μM) or vehicle control
(water) for 2 h. Medium was collected, and cells were surface-
biotinylated and lysed. Medium extracts were immunoblotted with
6E10 antibodies to sAPPa. Biotinylated proteins were
immunoblotted with antibodies to APP or ADAM10. B. Lysates from
vehicle-treated cultures were immunoblotted with antibodies to the
APP C-terminus. C. Results were quantitated, normalized to control
values, and expressed as means ± SEM from 4 or 5 experiments.
*Significantly different from vehicle-treated APP695/vector
transfectants. **Significantly different from carbachol-treated APP695/
vector transfectants.
Figure 4 Dyn I K44A promotes proteolytic processing of
ADAM10. A. HEK-M3 cells were transfected with empty vector,
ADAM10, or dyn I K44A, as indicated, and allowed to grow
overnight. The following day, the medium was replaced with DMEM
containing 1 μM L-685,458 or vehicle (DMSO). After 18 h, the cells
were surface-biotinylated and then lysed. Biotinylated proteins and
cell lysates were subjected to immunoblot analysis. B. Levels of the
most prominent ADAM10 CTF (~16 kDa) were quantitated,
normalized to levels in vehicle-treated ADAM10/dyn I K44A
transfectants, and expressed as means ± SEM from 4 experiments.
*Significantly different from corresponding ADAM10/vector
transfectants. **Significantly different from vehicle-treated ADAM10/
dyn I K44A-transfected cells.
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shedding (Figure 3).
Dynamin inhibition does not alter the distribution of
ADAM10 in raft and non-raft compartments
A subset of cellular APP is located within cholesterol-
rich subdomains of the plasma membrane known as
lipid rafts, where it is subject to proteolysis by b-a n dg-
secretases [31]. In contrast, the a-secretase ADAM10 is
largely excluded from lipid rafts [32]. The distribution
of APP and its secretases in different membrane
domains could therefore affect the balance between
amyloidogenic and non-amyloidogenic processing path-
ways. To determine if inhibition of ADAM10 internali-
zation affected its distribution between raft and non-raft
membrane regions, we employed a modified extraction
procedure utilizing Triton X-100 [33] to isolate deter-
gent-soluble and insoluble membrane fractions from
cells expressing ADAM10 and an empty vector, or dyn I
K44A. Equal amounts of protein from each fraction
were analyzed by immunoblotting with antibodies to the
ADAM10 C-terminus (Figure 6). Full-length mature and
immature ADAM10 and its CTF were detected in both
detergent-soluble and insoluble fractions (Figure 6A). By
expressing total protein levels in the detergent-soluble
fraction as a fraction of the combined protein levels in
both fractions, it was determined that approximately
90% of mature full-length ADAM10 and its CTF loca-
lized to the detergent-soluble non-raft compartment
(Figure 6B). Although co-expression of dynamin I K44A
increased levels of ADAM10 and its CTF in both frac-
tions, their distribution between raft and non-raft
domains was unaffected (Figure 6B). The separation of
raft and non-raft domains in this experiment was indi-
cated by the differential distribution of the transferrin
receptor (TfR) and flotillin-2 in the two fractions.
Approximately 97% of total TfR was localized in the
detergent-soluble fraction, consistent with its designa-
tion as a non-raft marker. Flotillin is used as a marker
for lipid rafts, but its relative distribution is very sensi-
tive to the detergent used for raft isolation [34]. In our
hands, 36% of total flotillin-2 was found in the deter-
gent-insoluble fraction in ADAM10 transfectants, and
23% in ADAM10/dynamin K44A co-transfectants (n =
2). The degree of enrichment that we observed lies
within the range reported by others using Triton X-100
extraction and sucrose gradient ultracentrifugation pro-
cedures [32,34].
Dynamin regulates N-cadherin proteolysis
These results, and earlier work from our laboratory and
others, indicate that dynamin regulates internalization
and proteolytic processing of both ADAM10 and its
substrate APP [16,17]. To extend this investigation to
other transmembrane proteins, we examined the effect
of the dynamin mutant on proteolytic processing of N-
cadherin, an adhesion protein that is a substrate for
ADAM10 and g-secretase [35,36]. HEK-M3 cells were
transiently transfected with human N-cadherin and
either empty vector, or dyn I K44A, separated into
detergent-soluble and insoluble fractions, and subjected
to immunoblot analysis. The abundance of a ~40 kDa
CTF of N-cadherin, a fragment previously shown to be
a product of ADAM-mediated proteolysis [35,36], was
increased in cells co-expressing dyn I K44A. The
increase was more prominent in the non-raft compart-
ment (Figure 6C). These results suggest that, as shown
for APP and ADAM10, inhibition of dynamin function
increases ADAM-mediated cleavage of N-cadherin,
thereby promoting formation of a CTF. In the case of
N-cadherin, increasing its proteolysis may potentiate its
ability to act as a repressor of the transcriptional coacti-
vator CBP (CREB binding protein) [35].
Figure 5 Stimulation of M3 receptors does not accelerate
formation of the ADAM10 CTF. A. HEK-M3 cells were transfected
with empty vector, ADAM10, or dyn I K44A, as indicated. After 48 h
cells were pre-incubated for 1 h in serum-free DMEM, then
incubated in fresh DMEM in the presence of carbachol (100 μM) or
vehicle control for 2 h. Cell lysates were prepared and subjected to
immunoblot analysis. B. Levels of the most prominent ADAM10 CTF
(~16 kDa) were quantitated, normalized to levels in vehicle-treated
ADAM10/dyn I K44A transfectants, and expressed as means ± SEM
from 3-4 experiments. *Significantly different from corresponding
ADAM10 transfectants.
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Cleavage of APP by the a-secretases, ADAM10 and
ADAM17/TACE, is of physiological importance because
it precludes the formation of the toxic Ab peptide.
Moreover, the secreted APP ectodomain fragment,
sAPPa, promotes neural plasticity and neurogenesis,
and exhibits neuroprotective properties [6]. G-protein
coupled receptors, and compounds such as phorbol
esters that directly activate PKC, increase cleavage of
sAPPa by a-secretases, but the mechanism is not fully
understood [6]. In the present study, we examined the
effect of inhibiting dynamin-dependent endocytosis on
the activity of ADAM10 toward its substrate APP.
Although other ADAMs, notably ADAM17, are cap-
able of cleaving APP, the expression of APP in adult
mouse brain overlaps to a much greater extent with
ADAM10 than with ADAM17 [37]. Moreover, APP
shedding is nearly abolished in primary neurons from
mice null for ADAM10 [38], and in cell lines following
knockdown of ADAM10 [39], indicating that ADAM10
is the physiologically relevant a-secretase in brain. Co-
expression of ADAM10 with a dominant-negative dyna-
min mutant, dyn I K44A, increased surface expression
of both mature and immature forms, indicating that
endocytosis of ADAM10, like that of APP [16,17] is
dynamin-dependent. An earlier report showed that
Figure 6 The distribution of ADAM10 between raft and non-raft membrane regions is not affected by expression of dyn I K44A. A.
HEK-M3 cells were transfected with ADAM10, or dyn I K44A, as indicated. Controls received empty vector alone. After 48 h cells were
fractionated into detergent-soluble and insoluble fractions. Equal amounts of protein from each fraction were size-fractionated on SDS gels and
analyzed by immunoblotting with antibodies to ADAM10, the transferrin receptor (TfR) or the raft protein flotillin 2. B. Total ADAM10 or ADAM10
CTF levels in each fraction were calculated (band intensity × (total fraction volume/volume loaded)) and the amount in the detergent-soluble
fraction was divided by the sum of the amounts in both fractions, to determine the fractional distribution of each protein in the non-raft
compartment. Results are expressed as means ± SEM from 3 experiments. C. HEK-M3 cells were transfected with N-cadherin and empty vector,
or dyn I K44A, fractionated into detergent-soluble and insoluble fractions, and analyzed by immunoblotting with antibodies to the N-cadherin C-
terminus. The two halves of each blot were captured from a single image. Several unrelated lanes that appeared on the original images have
been omitted for clarity.
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(MT1-MMP) is inhibited by a dynamin K44A mutant,
resulting in increased cleavage of its substrate pro-
MMP2 [40]. Thus, modulation of internalization could
be a general mechanism regulating the activity of trans-
membrane metalloproteases toward their substrates.
Several laboratories have examined the effects of
kinase activation on ADAM trafficking and protease
activity. PMA caused down-regulation of ADAM17/
TACE surface expression in Jurkat and THP-1 cells
[41], and a transient increase followed by a decline in
HeLa cells. The latter response was blocked by an inhi-
bitor of mitogen-activated protein kinase kinase, and by
mutation of threonine 735 to alanine of ADAM17/
TACE [42]. PMA also increased degradation of the
m a t u r ep r o c e s s e df o r mo fA D A M 1 7 / T A C E ,b u tn o t
ADAM10, in HEK293 cells [43], and promoted the
translocation of ADAM10 to the cell membrane in glio-
blastoma cells [44]. Taken together, the evidence indi-
cates that PKC-regulated activation of ADAM10, or
ADAM17/TACE, may be associated with alterations in
trafficking in some cell types; however, neither PMA
nor M3 receptor activation appear to regulate cell-sur-
face expression of ADAM10 in HEK cells (Figure 3 and
data not shown). Thus, the ability of these activators to
promote APP ectodomain shedding in our model is not
mediated by inhibition of internalization of either
ADAM10, or its substrate APP [17].
Overexpression of ADAM10 increased constitutive,
but not carbachol-evoked release of APP695 from HEK-
M3 cells (Figure 3). Even in the absence of carbachol,
surface APP695 was greatly reduced in ADAM10/APP695
co-transfectants (Figure 3), suggesting that under these
conditions the response to carbachol is limited by the
availability of APP695. This interpretation is supported
by an earlier report, which showed that ADAM10 over-
expression caused a much greater fold-increase in basal
than in PMA-stimulated APP shedding from HEK cells,
whereas a dominant negative ADAM10 mutant inhib-
ited PMA-stimulated APP shedding by approximately
75% [45]. Interestingly, surface levels of immature
ADAM10, but not mature ADAM10, were increased in
cells co-transfected with APP695, relative to levels in
cells expressing ADAM10 and empty vector (Figure 3).
This suggests that the association of APP with
ADAM10 inhibits the processing of ADAM10 by pro-
protein convertases, but how or where in the cell this
occurs is unknown.
In addition to increasing surface expression of
ADAM10, the dynamin mutant caused a marked eleva-
tion in cellular levels of an ADAM10 CTF, the abun-
dance of which was further increased by the g-
secretase inhibitor L-685,458 (Figure 4). This is consis-
tent with earlier reports that ADAM10 is subject to
proteolysis by ADAM9 or 15, generating a CTF that is
as u b s t r a t ef o rg -secretase [19-21], and suggests that
the cleavage of ADAM10 occurs at the cell surface. As
with surface expression of ADAM10, generation of the
ADAM10 CTF was not affected by carbachol (Figure
5), in contrast with an earlier report that PMA
increases ADAM10 shedding in SH-SY5Y neuroblas-
toma cells [20]. The reasons for this discrepancy are
unclear, but could be related to cell-specific differ-
ences, which also appear to underlie the varying effects
of PKC activators on ADAM10 trafficking. Because of
the potential signaling role of the ADAM10 CTF [19]
it would be of interest to identify factors that regulate
generation of this fragment. One possible mechanism
could involve alterations in ADAM10 endocytosis
resulting from direct interactions with other cell sur-
face proteins. An example of such a mechanism is the
modulation of APP internalization and processing by
members of the low-density lipoprotein receptor-
related protein (LRP) family [46]. Notably, binding to
LRP1B retains APP at the cell surface, increasing its
cleavage by a-secretase, and reducing Ab generation
[46,47]. Similarly, F-spondin, a secreted signaling mole-
cule implicated in neuronal development and repair
[48], binds to both the APP ectodomain and the apoli-
poprotein receptor ApoE2, promoting sAPPa release,
and inhibiting cleavage by b-secretase [49,50]; both
these effects are consistent with reduced internaliza-
tion. We predict that binding partners of ADAM10
could affect its processing in a similar way.
Evidence from multiple laboratories indicates that
amyloidogenic APP processing occurs in lipid rafts,
whereas processing by ADAMs is confined to non-raft
regions [31]. Disruption of raft domains by depleting
membrane cholesterol shifts APP processing in favor of
non-amyloidogenic processing. This could reflect the
displacement of APP from raft domains, and away from
b-a n dg-secretases [31,51], but might also be due in
part to inhibition of endocytosis [52]. Although dynamin
I K44A expression increased surface levels and ectodo-
main cleavage of mature ADAM10, there was no
accompanying change in the partitioning of either full-
length ADAM10 or its CTF in raft and non-raft
domains (Figure 6). Thus, the effects of the dynamin
mutant on ADAM proteolysis are likely simply to reflect
the accumulation of ADAM10, and possibly of the
ADAM that targets it, at the cell surface. To our knowl-
edge, the effect of dynamin inhibition on the distribu-
tion of APP in membrane subdomains has not been
addressed. However, like ADAM10 itself, the ADAM10
substrate N-cadherin underwent increased proteolysis in
the presence of dyn I K44A, without altering its distri-
bution between Triton-soluble and insoluble membrane
domains (Figure 6C).
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tions in its trafficking to or from the cell surface could
affect its activity towards any or all of them, thereby
regulating their biological activity. In the case of APP
and N-cadherin, this could inhibit their ability to pro-
mote cell-cell adhesion, neuronal development and
synaptogenesis [54,55], but at the same time would
increase the signaling functions of their liberated C-
terminal fragments [35,56]. Increased generation of the
ADAM10 CTF, also a consequence of decreased inter-
nalization, might exert biological effects of its own [19],
but these remain to be elucidated.
Conclusions
Our results demonstrate that the a-secretase ADAM10
is internalized by a dynamin-dependent mechanism.
Inhibition of endocytosis by co-expression of a domi-
nant negative dynamin mutant increased surface expres-
sion of ADAM10, and promoted its proteolysis,
generating a prominent CTF. Neither surface expression
nor proteolysis of ADAM10 was affected by activation
of muscarinic M3 receptors, despite the ability of this
PKC-coupled signaling pathway to robustly stimulate
APP shedding. Inhibition of dynamin also promoted
cleavage of the ADAM substrate N-cadherin, but did
not affect the membrane localization of either ADAM10
or N-cadherin, which were associated predominantly
with non-raft domains. It will be of interest to identify
physiological factors that regulate ADAM10 internaliza-
tion, as these have the potential to modulate cell-cell
contacts mediated by ADAM substrates such as APP
and N-cadherin, and to influence the generation and
signaling functions of the CTFs of both ADAM10 and
its targets.
Methods
Materials
Antibodies and other reagents were obtained from the fol-
lowing sources: 6E10 antibodies to sAPPa from Signet
Laboratories (Dedham, MA), rabbit antibodies to the C-
terminus of APP (APP-CT) from Zymed Labs (San Fran-
cisco, CA), mouse monoclonal antibodies to dynamin I
and goat polyclonal antibodies to the ADAM10 prodo-
main from Santa Cruz Biotechnology (Santa Cruz, CA),
rabbit antibodies to the C-terminus of ADAM10 from
Chemicon International (Temecula CA), and mouse anti-
bodies to the N-cadherin C-terminus from BD Biosciences
(San Jose, CA). Goat anti-mouse IgG and goat anti-rabbit
IgG peroxidase-conjugated secondary antibodies were
from BioRad (Hercules CA). Mouse anti-goat/sheep IgG
peroxidase-conjugated antibody was obtained from Sigma.
Decanoyl-arg-val-lys-arg-chloromethylketone (Dec-RVKR-
CMK) and [(2R, 4R 5S)-2-Benzyl-5-(Boc-amino)-4-
hydroxy-6-phenyl-hexanoyl]-Leu-Phe-NH2 (L-685,458)
were purchased from Bachem Bioscience (King of Prussia,
PA), Mini-gels and reagents for electrophoresis were
obtained from BioRad (Hercules CA), and PVDF (polyvi-
nylidene difluoride) membranes were purchased from
Millipore (Billerica, MA). 1,10-Phenanthroline, 2-mercap-
toethanesulfonic acid, carbachol (carbamylcholine chlor-
ide) and PMA were obtained from Sigma-Aldrich (St.
Louis MO). Sulfo-NHS-SS-Biotin was purchased from
Pierce (Rockford, IL), Other reagents and materials were
acquired from Fisher Scientific (Pittsburgh PA).
Cell culture
HEK-M3 cells (HEK cells stably transfected with M3
muscarinic receptors) were grown in Dulbecco’s
Modified Eagle Medium (DMEM)/F-12 supplemented
with 10% fetal bovine serum (Invitrogen, Carlsbad
CA) and maintained at 37°C in an atmosphere of 95%
air, 5% CO2. The HEK-M3 cell line has been exten-
sively characterized in our laboratory with respect to
both M3 receptor signaling and APP metabolism
[17,30,57,58].
Transient transfections
Plasmids encoding the following proteins were used for
transient transfections: APP695 (a gift from Dr. Carmela
Abraham), dyn I K44A (a gift from Dr. Marc Caron),
HA-ADAM10 (a gift from Dr. Falk Fahrenholz) and N-
cadherin (purchased from Origene Technologies, Inc.,
Rockville MD). Cells were transfected with the desired
plasmid, or with an empty pcDNA3 vector, using Lipo-
fectAMINE Plus™ reagent (Invitrogen) according to the
manufacturer’s specifications. Experiments were carried
out 48 h later.
Cell surface biotinylation
HEK cells were pre-incubated in serum-free DMEM for
1 h, and then washed in PBS, pH 7.9, supplemented
with 1 mM Ca
++ and 1 mM Mg
++. To biotinylate sur-
face proteins, the cells were incubated for 30 min with
Sulfo-NHS-SS-Biotin (0.5 mg/ml in PBS, Pierce, Rock-
ford, IL). Culture dishes were kept on ice and gently
rocked during the incubation period. The biotin reagent
was quenched by treating the cells with two 15 min
washes of 50 mM glycine in PBS. Cells were rinsed
again with PBS and lysed in a buffer containing 50 mM
Tris-HCl (pH 7.5), 150 mM NaCl, 2 mM AEBSF (4-(2-
aminoethyl) benzenesulfonyl fluoride), 1 μg/ml leupep-
tin, 1% (v/v) nonidet P-40, 0.05% (w/v) SDS, 0.5% (w/v)
deoxycholate, and 10 mM 1,10 phenanthroline monohy-
drate. Lysates were incubated overnight with streptavi-
din-coated agarose beads (Pierce, Rockford, IL) at 4°C in
a rotary mixer to isolate biotin-labeled proteins. These
were size-fractionated on SDS gels, and analyzed by
immunoblotting.
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The protein content of cell lysates was measured using the
bicinchoninic acid reagent (Sigma, St Louis CA). Medium
was collected, cleared by centrifugation, desalted, lyophi-
lized, and resuspended in SDS-PAGE loading buffer, as
previously described [57]. Lysates were centrifuged to
remove insoluble material, and diluted in 6× loading buf-
fer. Samples were normalized for protein content and size-
fractionated on 7.5%, 10-20%, or 4-20% Tris-HCl mini-
gels. Proteins were transferred to PVDF membranes,
blocked for 2 h in 5%-powdered milk in Tris-buffered sal-
ine with 0.15% Tween-20 for 2 h, and probed overnight
with primary antibodies. Membranes were washed and
incubated with goat anti-mouse IgG, mouse anti-goat IgG
or goat anti-rabbit IgG peroxidase-conjugated secondary
antibodies and bands were detected using an enhanced
chemiluminescence reagent (Pierce, Rockford IL). Approx-
imate molecular weights were estimated using prestained
standards from both BioRad (Hercules, CA) and Invitro-
gen (Carlsbad, CA). Membranes were imaged on a Kodak
440CF Image Station and quantitated using Kodak 1D
Image Analysis software.
Preparation of detergent-resistant membrane fractions
Membrane fractions were prepared according to the
method of Adam et al. [33]. Briefly, cells were rinsed with
PBS, suspended in buffer M containing 50 mM HEPES
pH 7.4, 10 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA plus
protease/phosphatase inhibitor cocktail (Thermo Scienti-
fic), homogenized with 12 strokes in a Potter-Elvehjem tis-
sue grinder, and centrifuged in a refrigerated
microcentrifuge at 4°C for 5 min at 500 × g to pellet
nuclei. The supernatant was decanted and centrifuged at
16,000 × g for 10 min at 4°C, the pellet was resuspended
in buffer A (25 mM 2-(N-morpholino)-ethanesulfonic acid
p H6 . 5a n d1 5 0m MN a C l )a n dt h e nc o m b i n e dw i t ha n
equal volume of buffer A containing 2% Triton X-100 and
protease/phosphatase inhibitor cocktail. The samples were
incubated on a rocking platform for 60 min on ice, then
centrifuged at 16,000 × g for 20 min at 4°C. Supernatants
were reserved as the Triton-soluble fraction. The pellet
was rinsed with buffer A, resuspended in buffer B (20 mM
Tris-HCl pH 7.6, 150 mM NaCl, 60 mM b-octylglucoside
and protease/phosphatase inhibitor cocktail), and incu-
bated on a rocking platform for 30 min on ice. The sam-
ples were centrifuged at 16,000 × g for 20 min at 4°C, and
the supernatants collected as the Triton-insoluble fraction.
Aliquots were assayed for protein content, and the
remainder was diluted with 6× gel loading buffer and used
for immunoblot analysis.
Statistical analysis
Data are reported as means ± the standard error of the
mean (S.E.M). Data were analyzed by Student’s t-test or
by ANOVA (analysis of variance) and Fisher’s Least Sig-
nificant Difference test. Differences were taken to be sig-
nificant at p < 0.05. Statistical analyses were carried out
using Systat software version 5.2.1 (SPSS, Inc., Chicago,
IL).
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